Mitochondria: The Anti- cancer Target for the Third Millennium
Springer Nature
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Chapter title |
Exploiting Celecoxib in Cancer Therapy
|
|---|---|
| Chapter number | 5 |
| Book title |
Mitochondria: The Anti- cancer Target for the Third Millennium
|
| Published by |
Springer, Dordrecht, January 2014
|
| DOI | 10.1007/978-94-017-8984-4_5 |
| Book ISBNs |
978-9-40-178983-7, 978-9-40-178984-4
|
| Authors |
Verena Jendrossek |
Mendeley readers
The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 13 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 4 | 31% |
| Other | 2 | 15% |
| Student > Master | 2 | 15% |
| Student > Ph. D. Student | 1 | 8% |
| Student > Bachelor | 1 | 8% |
| Other | 1 | 8% |
| Unknown | 2 | 15% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 4 | 31% |
| Chemistry | 3 | 23% |
| Agricultural and Biological Sciences | 2 | 15% |
| Medicine and Dentistry | 1 | 8% |
| Computer Science | 1 | 8% |
| Other | 0 | 0% |
| Unknown | 2 | 15% |